MENU
NKTR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Nektar Therapeutics (NKTR) Ownership - Who owns Nektar Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
455 Mission Bay Boulevard South
Phone
+1 415 482-5300
Employees
137
Web
https://www.nektar.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
215.82M
P/E Ratio
N/A
Total Cash
76.96M
Projected Growth
N/A
Total Debt
114.08M
Revenue
N/A
Risk (Beta)
0.89
Dividend Yield
N/A
Total Cash/Share
0.42
Total Debt/Equity
N/A
Revenue/Share
0.46 USD as % of share price
Fundamentals
NKTR
Capitalization
216M
P/E Ratio
N/A
Risk (Beta)
0.89
Dividend Yield
N/A
Total Cash
77M
Total Cash/Share
0.42
Total Debt
114M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.46%
Revenue
N/A
ROE
N/A
Book Value
127M
P/B Ratio
4.42
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
19K
Current Ratio
6.10
Current Revenue Per Employee
157948.90
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
60.56
Revenue To Assets
N/A
Shares Held By Institutions
210M
Shares Outstanding - Current
184M
Total Liabilities
269M
Total Volume MTD
N/A
Value
N/A
Gain YTD
107.080
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of inhalation drug delivery systems
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
455 Mission Bay Boulevard South
Phone
+1 415 482-5300
Employees
137
Web
https://www.nektar.com